Evidence map›Paper›PMID 27011213›Full record

ArticleThe journal of headache and pain2016

The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.

Malgorzata Pihut, Ewa Ferendiuk, Michal Szewczyk, Katarzyna Kasprzyk, Mieszko Wieckiewicz

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in The journal of headache and pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03371888 phase2 / phase3completednot on this mapstarted 2017, after this paper: background citation

The Platelet -Rich Plasma in the Therapy of Temporomandibular Disorders

TypeinterventionalSponsorMedical University of SilesiaRan2017 to 2019Enrolled58ConditionsPRP, Temporomandibular Disorder, Myalgia, BruxismArmsPlatelet-Rich Plasma intramuscular injections, Placebo Comparator: 0,9% NaCl intramuscular injections
NCT05651256 phase2 / phase3completednot on this mapstarted 2021, after this paper: background citation

Preliminary Findings of the Efficacy of Botulinum Toxin in Temporomandibular Disorders: A Randomized Clinical Trial

TypeinterventionalSponsorUniversity of SalamancaRan2021 to 2021Enrolled20ConditionsTemporomandibular Joint Disorder BilateralArmsBotulinum toxin type A injection
NCT06676475 phase2 / phase3not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Comparison of the Effectiveness of Botulinum Toxin and Magnesium Sulfate Injections in the Treatment of Myofascial Trigger Points in the Masseter Muscle Randomized Controlled Clinical Trial

TypeinterventionalSponsorMisr University for Science and TechnologyRan2024 to 2025Enrolled60ConditionsMyofacial Pain, Trigger Points, MyofascialArmsMgSO4, BOTOX-A, Saline (NaCl 0,9 %) (placebo)
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Malgorzata PihutDepartment of Dental Prosthetics, Jagiellonian University in Krakow, College of Medicine, Institute of Dentistry, 4 Montelupich St., 31-155, Krakow, Poland.
Ewa FerendiukDepartment of Dental Prosthetics, Jagiellonian University in Krakow, College of Medicine, Institute of Dentistry, 4 Montelupich St., 31-155, Krakow, Poland.
Michal SzewczykDepartment of Dental Prosthetics, Jagiellonian University in Krakow, College of Medicine, Institute of Dentistry, 4 Montelupich St., 31-155, Krakow, Poland.
Katarzyna KasprzykDepartment of Neurology, Jagiellonian University in Krakow, College of Medicine, 3 Botaniczna St., 31-503, Krakow, Poland.
Mieszko WieckiewiczDepartment of Prosthetic Dentistry, Faculty of Dentistry, Wroclaw Medical University, 26 Krakowska St., 50-425, Wroclaw, Poland. m.wieckiewicz@onet.pl.
Jagiellonian University · PLWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTemporomandibular joint dysfunction are often accompanied by symptoms of headache such as tension-type headache which is the most frequent spontaneous primary headache. Masseter muscle pain is commonly reported in this group. The purpose of the study was to assess the efficiency of intramuscular botulinum toxin type A injections for treating masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.

methodsThis prospective outcome study consisted of 42 subjects of both genders aged 19-48 years diagnosed with masseter muscle pain related to temporomandibular joint dysfunction and tension-type headache. The subjects were treated by the intramuscular injection of 21 U (mice units) of botulinum toxin type A (Botox, Allergan) in the area of the greatest cross-section surface of both masseter bellies. Pain intensity was evaluated using visual analogue scale (VAS) and verbal numerical rating scale (VNRS) 1 week before the treatment and 24 weeks after the treatment. The obtained data were analyzed using the Wilcoxon matched pairs test (p ≤ 0,005).

resultsThe results of this study showed a decrease in the number of referred pain episodes including a decrease in pain in the temporal region bilaterally, a reduction of analgesic drugs intake as well as a decrease in reported values of VAS and VNRS after injections (p = 0,000).

conclusionsThe intramuscular botulinum toxin type A injections have been an efficient method of treatment for masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.

Indexed as

AdultBotulinum Toxins, Type AFemaleHumansInjections, IntramuscularMaleMasseter MuscleMiddle AgedMyalgiaNeuromuscular AgentsPain MeasurementProspective StudiesTemporomandibular Joint Dysfunction SyndromeTension-Type HeadacheTreatment OutcomeYoung AdultBotulinum Toxins, Type ANeuromuscular AgentsBotulinum toxinMasseter muscle painTemporomandibular joint dysfunctionTension-type headache

Identifiers

PMID27011213
PMCPMC4807183
OpenAlexW2306507320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.